Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Delayed Quote USD

Jasper Therapeutics, Inc. (JSPRW)

Compare
0.0801
-0.0628
(-43.95%)
At close: April 1 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
76,239
76,239
68,861
51,196
36,833
Operating Income
-76,239
-76,239
-68,861
-51,196
-36,833
Net Non Operating Interest Income Expense
5,058
5,058
5,199
701
--
Other Income Expense
-88
-88
-803
12,810
6,196
Pretax Income
-71,269
-71,269
-64,465
-37,685
-30,637
Net Income Common Stockholders
-71,269
-71,269
-64,465
-37,685
-30,637
Diluted NI Available to Com Stockholders
-71,269
-71,269
-64,465
-37,685
-30,637
Total Operating Income as Reported
-76,239
-76,239
-68,861
-51,196
-36,833
Total Expenses
76,239
76,239
68,861
51,196
36,833
Net Income from Continuing & Discontinued Operation
-71,269
-71,269
-64,465
-37,685
-30,637
Normalized Income
-71,269
-71,269
-63,908
-50,610
-36,913
Interest Income
5,058
5,058
5,199
701
--
Net Interest Income
5,058
5,058
5,199
701
--
EBIT
-76,239
-76,239
-68,861
-51,196
-36,833
EBITDA
-74,866
-74,866
-67,753
-50,221
-36,456
Reconciled Depreciation
1,373
1,373
1,108
975
377
Net Income from Continuing Operation Net Minority Interest
-71,269
-71,269
-64,465
-37,685
-30,637
Total Unusual Items Excluding Goodwill
--
--
-557
12,925
6,276
Total Unusual Items
--
--
-557
12,925
6,276
Normalized EBITDA
-74,866
-74,866
-67,196
-63,146
-42,732
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade